Uncategorised - European Medical Journal

Shortened Rabies Vaccination Regimen Shows Comparable Efficacy

The trial highlighted that the Zagreb regimen led to fewer doses and a shorter vaccination period, improving compliance and cost-effectiveness.

Cystic Fibrosis Diabetes Linked to Protein Deficiency

Impaired insulin secretion in cystic fibrosis-related diabetes (CFRD) is driven by reduced expression of the GLP-1 receptor (GLP-1R) in pancreatic islet cells, according to the results of a new study.

New Trial in HIV Prevention With Lenacapavir

Twice-yearly lenacapavir injections have shown remarkable efficacy in preventing HIV infection, offering a promising alternative to daily oral PrEP for males and gender-diverse individuals.

Robot-Assisted Surgery: Transforming Bladder Cancer Treatment Outcomes

Evidence from multiple studies and randomised controlled trials suggests that robot-assisted radical cystectomy delivers improved perioperative outcomes.

Stress Echocardiography Predicts Five-Year Cardiovascular Risks

Stress echocardiography predicts five-year cardiovascular risk, guiding treatment for high-risk patients and offering reassurance for low-risk cases.

Unveiling the Gender Divide in Systemic Sclerosis Lung Complications

Men with systemic sclerosis are more prone to ILD, while women face higher risks of SAD, a study reveals critical sex-related differences.

Early Menstruation Tied to Lower Breast Cancer Screening Rates

Despite their higher risk, women with early menarche in Côte d’Ivoire are less likely to undergo breast cancer screenings, a new study finds.

Combination Treatment Shows Promise for Advanced Lung Cancer

A new study has explored the effectiveness of combining transpulmonary chemoembolisation and microwave ablation for treating non-small cell lung cancer…

Gut Microbiome Impacts Tamoxifen Efficacy

A recent study has revealed that the gut microbiota plays a critical role in tamoxifen’s metabolism, influencing its absorption and bioavailability.

15-Year Colonoscopy Interval Safe for Low-Risk Patients

Individuals without a family history of colorectal cancer could safely extend their colonoscopy screenings from the standard 10-year interval to 15 years.